Big Willy/Hash/Sal,
You are all so keen to point out that the company has not been profitable. How wise and insightful you all are! Do you think us long-term holders only read braille??? As you also know, there are clear reasons for this. In descending order of importance: Covid pandemic, Alto lending debacle, disputes with payments, need to switch to CTV advertising, lack of company oversight. Okay before you all add to this list and start arguing, I want to point out that despite serious head winds, this company has survived. I don't want to rile you up, but our CEO is a fighter and a rather intelligent one at that. He is resilient. He learns from his mistakes. He has adapted. He does listen to his detractors. So, come on, quit the personal attacks, let's review the upcoming quarterly. I suggest that it will look very healthy and will provide opportunity. Some barnacles here on Hot Copper will not be the ones to profit. Many young and resourceful crustaceans will take their place.
- Forums
- ASX - By Stock
- CTV
- EN1 Renaissance
EN1 Renaissance, page-25
-
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CTV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online